Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-089050

Chief Operating Officer sold 4,375 shares at $4.26 ($18,659)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bertrand William C JR Chief Operating Officer 2021-07-02 Sale −4,375 $4.26 $18,659 7,329 D
Open-market sales · 4,375 sh · avg $4.26 · $18,659
Loading xslF345X03/tm2121284-9_4seq1.xml…